Drug development in the era of precision medicine in oncology-Clues beyond randomization

Chin Clin Oncol. 2021 Jun;10(3):23. doi: 10.21037/cco-21-29. Epub 2021 Apr 23.

¹ Department of Drug Development and Innovation (D3i), Institut Curie, Paris & Saint-Cloud, France; INSERM U900 Research Unit, Institut Curie, Saint-Cloud, France.
² Department of Biostatistics, IUCT-Oncopole, Toulouse, France.
³ Department of Drug Development and Innovation (D3i), Institut Curie, Paris & Saint-Cloud, France; INSERM U900 Research Unit, Institut Curie, Saint-Cloud, France; Faculty of Medicine, Paris-Saclay University, Paris, France.

No abstract available

MeSH terms